Quality and Adoption of COVID-19 Tracing Apps and Recommendations for Development: Systematic Interdisciplinary Review of European Apps.


Journal

Journal of medical Internet research
ISSN: 1438-8871
Titre abrégé: J Med Internet Res
Pays: Canada
ID NLM: 100959882

Informations de publication

Date de publication:
02 06 2021
Historique:
received: 16 02 2021
accepted: 22 04 2021
revised: 19 04 2021
pubmed: 24 4 2021
medline: 29 6 2021
entrez: 23 4 2021
Statut: epublish

Résumé

Simulation study results suggest that COVID-19 contact tracing apps have the potential to achieve pandemic control. Concordantly, high app adoption rates were a stipulated prerequisite for success. Early studies on potential adoption were encouraging. Several factors predicting adoption rates were investigated, especially pertaining to user characteristics. Since then, several countries have released COVID-19 contact tracing apps. This study's primary aim is to investigate the quality characteristics of national European COVID-19 contact tracing apps, thereby shifting attention from user to app characteristics. The secondary aim is to investigate associations between app quality and adoption. Finally, app features contributing to higher app quality were identified. Eligible COVID-19 contact tracing apps were those released by national health authorities of European Union member states, former member states, and countries of the European Free Trade Association, all countries with comparable legal standards concerning personal data protection and app use voluntariness. The Mobile App Rating Scale was used to assess app quality. An interdisciplinary team, consisting of two health and two human-computer interaction scientists, independently conducted Mobile App Rating Scale ratings. To investigate associations between app quality and adoption rates and infection rates, Bayesian linear regression analyses were conducted. We discovered 21 national COVID-19 contact tracing apps, all demonstrating high quality overall and high-level functionality, aesthetics, and information quality. However, the average app adoption rate of 22.9% (SD 12.5%) was below the level recommended by simulation studies. Lower levels of engagement-oriented app design were detected, with substantial variations between apps. By regression analyses, the best-case adoption rate was calculated by assuming apps achieve the highest ratings. The mean best-case adoption rates for engagement and overall app quality were 39.5% and 43.6%, respectively. Higher adoption rates were associated with lower cumulative infection rates. Overall, we identified 5 feature categories (symptom assessment and monitoring, regularly updated information, individualization, tracing, and communication) and 14 individual features that contributed to higher app quality. These 14 features were a symptom checker, a symptom diary, statistics on COVID-19, app use, public health instructions and restrictions, information of burden on health care system, assigning personal data, regional updates, control over tracing activity, contact diary, venue check-in, chats, helplines, and app-sharing capacity. European national health authorities have generally released high quality COVID-19 contact tracing apps, with regard to functionality, aesthetics, and information quality. However, the app's engagement-oriented design generally was of lower quality, even though regression analyses results identify engagement as a promising optimization target to increase adoption rates. Associations between higher app adoption and lower infection rates are consistent with simulation study results, albeit acknowledging that app use might be part of a broader set of protective attitudes and behaviors for self and others. Various features were identified that could guide further engagement-enhancing app development.

Sections du résumé

BACKGROUND
Simulation study results suggest that COVID-19 contact tracing apps have the potential to achieve pandemic control. Concordantly, high app adoption rates were a stipulated prerequisite for success. Early studies on potential adoption were encouraging. Several factors predicting adoption rates were investigated, especially pertaining to user characteristics. Since then, several countries have released COVID-19 contact tracing apps.
OBJECTIVE
This study's primary aim is to investigate the quality characteristics of national European COVID-19 contact tracing apps, thereby shifting attention from user to app characteristics. The secondary aim is to investigate associations between app quality and adoption. Finally, app features contributing to higher app quality were identified.
METHODS
Eligible COVID-19 contact tracing apps were those released by national health authorities of European Union member states, former member states, and countries of the European Free Trade Association, all countries with comparable legal standards concerning personal data protection and app use voluntariness. The Mobile App Rating Scale was used to assess app quality. An interdisciplinary team, consisting of two health and two human-computer interaction scientists, independently conducted Mobile App Rating Scale ratings. To investigate associations between app quality and adoption rates and infection rates, Bayesian linear regression analyses were conducted.
RESULTS
We discovered 21 national COVID-19 contact tracing apps, all demonstrating high quality overall and high-level functionality, aesthetics, and information quality. However, the average app adoption rate of 22.9% (SD 12.5%) was below the level recommended by simulation studies. Lower levels of engagement-oriented app design were detected, with substantial variations between apps. By regression analyses, the best-case adoption rate was calculated by assuming apps achieve the highest ratings. The mean best-case adoption rates for engagement and overall app quality were 39.5% and 43.6%, respectively. Higher adoption rates were associated with lower cumulative infection rates. Overall, we identified 5 feature categories (symptom assessment and monitoring, regularly updated information, individualization, tracing, and communication) and 14 individual features that contributed to higher app quality. These 14 features were a symptom checker, a symptom diary, statistics on COVID-19, app use, public health instructions and restrictions, information of burden on health care system, assigning personal data, regional updates, control over tracing activity, contact diary, venue check-in, chats, helplines, and app-sharing capacity.
CONCLUSIONS
European national health authorities have generally released high quality COVID-19 contact tracing apps, with regard to functionality, aesthetics, and information quality. However, the app's engagement-oriented design generally was of lower quality, even though regression analyses results identify engagement as a promising optimization target to increase adoption rates. Associations between higher app adoption and lower infection rates are consistent with simulation study results, albeit acknowledging that app use might be part of a broader set of protective attitudes and behaviors for self and others. Various features were identified that could guide further engagement-enhancing app development.

Identifiants

pubmed: 33890867
pii: v23i6e27989
doi: 10.2196/27989
pmc: PMC8174558
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e27989

Informations de copyright

©Leonie Kahnbach, Dirk Lehr, Jessica Brandenburger, Tim Mallwitz, Sophie Jent, Sandy Hannibal, Burkhardt Funk, Monique Janneck. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 02.06.2021.

Références

PLoS One. 2021 Feb 3;16(2):e0246524
pubmed: 33534839
JMIR Public Health Surveill. 2021 Jan 6;7(1):e25701
pubmed: 33326411
Eur J Psychotraumatol. 2020 Jan 9;11(1):1701788
pubmed: 32002136
JMIR Mhealth Uhealth. 2020 Apr 7;8(4):e18936
pubmed: 32240973
Lancet Digit Health. 2020 Nov;2(11):e607-e621
pubmed: 32839755
Sci Adv. 2021 Apr 9;7(15):
pubmed: 33712416
J Med Internet Res. 2020 Aug 25;22(8):e20334
pubmed: 32614777
Psychol Bull. 1992 Jul;112(1):155-9
pubmed: 19565683
JMIR Mhealth Uhealth. 2019 Aug 05;7(8):e14991
pubmed: 31381501
Nat Hum Behav. 2021 Feb;5(2):247-255
pubmed: 33479505
Science. 2020 May 8;368(6491):
pubmed: 32234805
J Chiropr Med. 2016 Jun;15(2):155-63
pubmed: 27330520
J Med Internet Res. 2020 Dec 9;22(12):e23170
pubmed: 33197234
Science. 2020 Nov 13;370(6518):760-762
pubmed: 33184192
Lancet Public Health. 2020 Aug;5(8):e452-e459
pubmed: 32682487
Ir J Med Sci. 2020 Oct 16;:
pubmed: 33063226
Nat Hum Behav. 2020 May;4(5):451-459
pubmed: 32377018
Eur J Public Health. 2021 Feb 1;31(1):49-51
pubmed: 33340328
J Med Syst. 2020 Aug 10;44(9):164
pubmed: 32779002
Nature. 2021 May 12;:
pubmed: 33979832
JMIR Public Health Surveill. 2020 Sep 1;6(3):e20572
pubmed: 32755882
J Med Internet Res. 2020 Oct 6;22(10):e21299
pubmed: 33001828
JMIR Mhealth Uhealth. 2016 Jun 14;4(2):e74
pubmed: 27302310
JMIR Mhealth Uhealth. 2020 Aug 28;8(8):e19857
pubmed: 32759102
Health Educ Behav. 2020 Aug;47(4):531-535
pubmed: 32527161
Health Psychol Rev. 2018 Jun;12(2):111-125
pubmed: 29233060
Nat Hum Behav. 2020 Dec;4(12):1303-1312
pubmed: 33199859
JMIR Mhealth Uhealth. 2015 Mar 11;3(1):e27
pubmed: 25760773
Lancet Infect Dis. 2020 Oct;20(10):1151-1160
pubmed: 32559451
Swiss Med Wkly. 2020 May 17;150:w20282
pubmed: 32418194
J Med Internet Res. 2020 Dec 9;22(12):e21687
pubmed: 33295292
JMIR Mhealth Uhealth. 2020 Mar 27;8(3):e14479
pubmed: 32217504
PLoS One. 2020 Oct 29;15(10):e0241473
pubmed: 33120402
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
JMIR Mhealth Uhealth. 2020 Oct 9;8(10):e20741
pubmed: 32795998

Auteurs

Leonie Kahnbach (L)

Department of Health Psychology and Applied Biological Psychology, Leuphana University of Lüneburg, Lüneburg, Germany.
Competencies for Digitally-Enhanced Individualized Practice Project, Leuphana University of Lüneburg, Lüneburg, Germany.

Dirk Lehr (D)

Department of Health Psychology and Applied Biological Psychology, Leuphana University of Lüneburg, Lüneburg, Germany.

Jessica Brandenburger (J)

Institute for Interactive Systems, Technische Hochschule Lübeck, Lübeck, Germany.

Tim Mallwitz (T)

Institute for Interactive Systems, Technische Hochschule Lübeck, Lübeck, Germany.

Sophie Jent (S)

Department for Electrical Engineering and Computer Science, Technische Hochschule Lübeck, Lübeck, Germany.

Sandy Hannibal (S)

Department of Health Psychology and Applied Biological Psychology, Leuphana University of Lüneburg, Lüneburg, Germany.

Burkhardt Funk (B)

Institute of Information Systems, Leuphana University of Lüneburg, Lüneburg, Germany.

Monique Janneck (M)

Institute for Interactive Systems, Technische Hochschule Lübeck, Lübeck, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH